Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 4-(cyclohexyl(methyl)amino)piperidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

941303-25-9

Post Buying Request

941303-25-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

941303-25-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 941303-25-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,3,0 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 941303-25:
(8*9)+(7*4)+(6*1)+(5*3)+(4*0)+(3*3)+(2*2)+(1*5)=139
139 % 10 = 9
So 941303-25-9 is a valid CAS Registry Number.

941303-25-9Relevant academic research and scientific papers

Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety

Lv, Kai,Tao, Zeyu,Liu, Qian,Yang, Lu,Wang, Bin,Wu, Shuo,Wang, Apeng,Huang, Menghao,Liu, Mingliang,Lu, Yu

, p. 1 - 8 (2018/04/02)

We herein report the design and synthesis of benzothiazinones containing a piperidine moiety as new antitubercular agents based on the structure feature of IMB-ZR-1 discovered in our lab. Some of them were found to have good in vitro activity (MIC 1 μg/

NOVEL N-SULFAMOYL-PIPERIDINEAMIDES FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY AND RELATED CONDITIONS

-

Page/Page column 37, (2010/11/27)

The present invention relates to novel N-sulfamoyl-piperidineamides of general formula (I) and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the tre

N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

-

Page/Page column 16, (2010/11/27)

The present invention relates to novel N-sulfamoyl-piperidineamides of Formula I and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment of obesity and its concomitant and/or secondary diseases and related or other conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 941303-25-9